NovaBay Pharma (NBY) Misses Q2 EPS by 6c

August 11, 2016 5:09 PM EDT
Get Alerts NBY Hot Sheet
Trade NBY Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $1.76 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment